-
Kessler Topaz Meltzer & Check, LLP - Class Action Announcement for Akero Therapeutics, Inc. (AKRO): A Securities Class Action Lawsuit Has Been Filed Against Akero Therapeutics, Inc.
05 May 2024 15:15 GMT
…
Akero is a clinical stage drug development company which has yet to generate …
-
Are ‘global CROs’ the sole solution for multinational drug development clinical trials?
03 May 2024 07:58 GMT
… a forum for exchanges on drug development, company officials said.
Founded in 2000 …
-
Belfast Telegraph Business Awards 2024: Major NI company named Outstanding Business of the Year
03 May 2024 04:02 GMT
… who made tonight a success.”
Drug development company Almac Group, which is based …
-
Mstone Portfolio Company, Epygenix Therapeutics, Announces Agreement to be Acquired For Total Deal Value of $680M
02 May 2024 06:19 GMT
… and manages a portfolio of drug development companies. Mstone focuses on rare, pediatric …
-
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
01 May 2024 20:15 GMT
… “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics … is a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics …
-
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
01 May 2024 14:50 GMT
… : KZIA) is an oncology-focused drug development company, based in Sydney, Australia.
Our …
-
Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases
01 May 2024 12:00 GMT
… , Inc. ("Creyon"), a drug development company that engineers Oligonucleotide-Based Medicines …
-
Ellipses' next generation selective RET inhibitor EP0031/A400 cleared to start Phase 2
01 May 2024 11:15 GMT
… ("Ellipses"), a global drug development company focused on accelerating the development … Limited
Ellipses is a global drug development company based in London, focused on …
-
Philly daily roundup: UPenn’s AI master’s degree; Advice for EDA Tech Hubs; Last day of ACP
01 May 2024 11:17 GMT
… . [Colliers/Technical.ly]
• AI drug development company BioPhy is partnering with Every …
-
NASDAQ: AKRO: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Akero Therapeutics, Inc.
01 May 2024 02:40 GMT
…
Akero is a clinical stage drug development company which has yet to generate …